GLPHubglpresearchhub.com
Read-only archive. GLP Research Hub is a static community record — nothing here is for sale, no account is needed, and no vote you cast is counted. Why?
Single comment threadYou are looking at one branch of the compounding question that gets asked weekly, answered properly — 33 comments in the full submission. View in context.
4.1k
c/compounding·submitted 1 year ago by u/rekha_mwangi

the compounding question that gets asked weekly, answered properly

Questionbranch of 8 comments

Something I keep coming back to: the compounding question that gets asked weekly, answered properly. Asked for potency testing on the finished preparation. They had it. I had assumed they would not. On concentration, which is where I see people actually get hurt. A compounded vial can be filled at a different…

Read the full submission and all 33 comments →

This branch

8 comments, started 1 year ago
u/liver_enzyme_liz480 points·1 year ago

Salt form matters for mass: a preparation specified as one salt and dosed as the free base gives you a different amount of peptide for the same number on the label.

replysharereportpermalink
u/yannick_petrov-9 points·1 year ago

Careful. Naming a clinic without describing what actually happened turns this into a different kind of thread.

replysharereportpermalink
u/elise_ramos1 point·1 year ago

the shortage list is the whole legal hinge and people skip it

replysharereportpermalink
u/marit_laurent1 point·1 year ago

The intake asked me three questions and none of them were about my history. That told me everything I needed to know about the model.

replysharereportpermalink
[removed]1 point·1 year ago

[removed by moderator]

replysharereportpermalink
u/clara_danquah156 points·1 year ago

the label on a compounded vial is a legal document, read it

replysharereportpermalink
u/ismael_pires123 points·1 year ago

a 503B has to register and report, so there is a paper trail to ask for

replysharereportpermalink
u/rania_diallo64 points·1 year ago

This. Compounded preparations carry no equivalence claim, and treating them as generics is a category error people make constantly.

replysharereportpermalink

← back to the whole thread

About c/compounding

Compounded GLP-1s as a supply route: the 503A/503B distinction, the shortage-list mechanics that made compounding legal and then didn't, state board rules, telehealth prescriber models, and what a compounding pharmacy will and will not tell you about its API source.

53kmembers
95submissions
Oct 2023created
submissions / month, last year
Sponsored

Sigma-Aldrich Standards

Certified reference materials for peptide identity and purity work.

sigmaaldrich.com
c/compounding rules
  1. Regulatory claims need a citation to the actual rule, notice or docket.
  2. No pharmacy referral codes. Naming a pharmacy is fine; recruiting for it is not.
  3. API source questions are on-topic and pharmacies dodging them is newsworthy.
  4. Independent community. Nobody here sells anything, and anyone who tries is banned.
  5. Not medical advice. Describe what you did; never prescribe to a stranger.
  6. Claims need evidence. Batch numbers, dated screenshots, independent test reports, or a citation.
  7. No referral links, discount codes or affiliate URLs. Permanent ban, no appeal.
  8. No contact handles, wallet addresses or tracking numbers — they identify people.
  9. Be recognisably decent. Disagree hard, insult nobody.
Moderators
Volunteers. Unpaid, unaffiliated, and reachable through modmail only.
Before you read on

Several compounds discussed on GLP Research Hub are sold for research use only and are not approved for human use anywhere. Nothing here is medical advice and none of it is written by your clinician. If a post reads like an instruction, treat it as a description of what one stranger did.